Human Gene PIDD1 (ENST00000347755.10_11) from GENCODE V47lift37
|
|
Sequence and Links to Tools and Databases
|
|
Comments and Description Text from UniProtKB
|
|
ID: PIDD_HUMAN
DESCRIPTION: RecName: Full=p53-induced protein with a death domain; AltName: Full=Leucine-rich repeat and death domain-containing protein;
FUNCTION: Promotes apoptosis downstream of the tumor suppressor as component of the DNA damage/stress response pathway that connects p53/TP53 to apoptosis. Associates with NEMO/IKBKG and RIP1 and enhances sumoylation and ubiquitination of NEMO/IKBKG which is important for activation of the transcription factor NF-kappa-B. Associates with CASP2/caspase-2 and CRADD/RAIDD, and induces activation of CASP2 which an important regulator in apoptotic pathways. SUBUNIT: Interacts with FADD and MAP-kinase activating death domain/MADD. Forms a complex with IKBKG and with receptor- interacting serine-threonine kinase 1/RIP1. Forms also a complex named PIDDosome with CASP2 and CRADD. INTERACTION: P78560:CRADD; NbExp=6; IntAct=EBI-520427, EBI-520375; Q99750:MDFI; NbExp=3; IntAct=EBI-520427, EBI-724076; P78527:PRKDC; NbExp=6; IntAct=EBI-520427, EBI-352053; SUBCELLULAR LOCATION: Cytoplasm. Nucleus. TISSUE SPECIFICITY: Ubiquitous. INDUCTION: Induced by gamma-irradiation. SIMILARITY: Contains 1 death domain. SIMILARITY: Contains 7 LRR (leucine-rich) repeats. SIMILARITY: Contains 1 peptidase S68 domain. SIMILARITY: Contains 2 ZU5 domains. SEQUENCE CAUTION: Sequence=BAD92069.1; Type=Erroneous initiation; Sequence=BAD92186.1; Type=Erroneous initiation; Sequence=BAD92766.1; Type=Erroneous initiation; Sequence=CAD38708.1; Type=Erroneous initiation;
| |
|
|
Primer design for this transcript
|
|
MalaCards Disease Associations
|
|
Common Gene Haplotype Alleles
|
|
Press "+" in the title bar above to open this section.
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
mRNA Secondary Structure of 3' and 5' UTRs
|
|
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
| |
|
|
Protein Domain and Structure Information
|
|
InterPro Domains: Graphical view of domain structure IPR000488 - Death
IPR011029 - DEATH-like
IPR001611 - Leu-rich_rpt
IPR003591 - Leu-rich_rpt_typical-subtyp
IPR019502 - Peptidase_S68_pidd
IPR000906 - ZU5
Pfam Domains: PF00531 - Death domain
PF00791 - ZU5 domain
PF10461 - Peptidase S68
PF13855 - Leucine rich repeat
SCOP Domains: 47986 - DEATH domain
52047 - RNI-like
52058 - L domain-like
52075 - Outer arm dynein light chain 1
53067 - Actin-like ATPase domain
Protein Data Bank (PDB) 3-D Structure
ModBase Predicted Comparative 3D Structure on Q9HB75
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
Gene Details | | | | | |
Gene Sorter | | | | | |
| | Ensembl | | | |
| | | | | |
| | | | | |
|
| |
|
|
Gene Ontology (GO) Annotations with Structured Vocabulary
|
|
Molecular Function: GO:0005123 death receptor binding
GO:0005515 protein binding
Biological Process: GO:0006915 apoptotic process
GO:0006919 activation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0006974 cellular response to DNA damage stimulus
GO:0006977 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest
GO:0007165 signal transduction
GO:0042981 regulation of apoptotic process
GO:0043065 positive regulation of apoptotic process
GO:0043066 negative regulation of apoptotic process
GO:0051092 positive regulation of NF-kappaB transcription factor activity
GO:1902043 positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
GO:2001235 positive regulation of apoptotic signaling pathway
GO:2001238 positive regulation of extrinsic apoptotic signaling pathway
Cellular Component: GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005794 Golgi apparatus
GO:0005829 cytosol
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
AF465246 - Homo sapiens unknown mRNA. HH837078 - Sequence 5 from Patent EP2231168. HI214719 - Sequence 5 from Patent EP2076526. HV601521 - JP 2011500003-A/5: Novel siRNA Structures. HV708912 - JP 2012506450-A/10: Methods for treating eye disorders. HV856594 - JP 2010507387-A/5: Novel siRNAs and Methods of Use Thereof. HW061132 - JP 2012529430-A/7: METHODS FOR TREATING CHRONIC KIDNEY DISEASE. HW165081 - JP 2013102767-A/5: Novel siRNA's and Use Thereof. HW675589 - JP 2014210789-A/5: Novel siRNA Structures. HW835277 - JP 2015051004-A/5: Novel siRNA's and Use Thereof. JA482090 - Sequence 73 from Patent WO2011072091. JA538120 - Sequence 5 from Patent EP2371958. JB251940 - Sequence 7 from Patent EP2440214. JE980382 - Sequence 73 from Patent EP2862929. LP764839 - Sequence 7 from Patent EP3276004. HH837076 - Sequence 3 from Patent EP2231168. HH837077 - Sequence 4 from Patent EP2231168. HI214717 - Sequence 3 from Patent EP2076526. HI214718 - Sequence 4 from Patent EP2076526. HV601519 - JP 2011500003-A/3: Novel siRNA Structures. HV601520 - JP 2011500003-A/4: Novel siRNA Structures. HV708910 - JP 2012506450-A/8: Methods for treating eye disorders. HV708911 - JP 2012506450-A/9: Methods for treating eye disorders. HV856592 - JP 2010507387-A/3: Novel siRNAs and Methods of Use Thereof. HV856593 - JP 2010507387-A/4: Novel siRNAs and Methods of Use Thereof. HW061130 - JP 2012529430-A/5: METHODS FOR TREATING CHRONIC KIDNEY DISEASE. HW061131 - JP 2012529430-A/6: METHODS FOR TREATING CHRONIC KIDNEY DISEASE. HW165079 - JP 2013102767-A/3: Novel siRNA's and Use Thereof. HW165080 - JP 2013102767-A/4: Novel siRNA's and Use Thereof. HW675587 - JP 2014210789-A/3: Novel siRNA Structures. HW675588 - JP 2014210789-A/4: Novel siRNA Structures. HW835275 - JP 2015051004-A/3: Novel siRNA's and Use Thereof. HW835276 - JP 2015051004-A/4: Novel siRNA's and Use Thereof. JA482088 - Sequence 71 from Patent WO2011072091. JA482089 - Sequence 72 from Patent WO2011072091. JA538118 - Sequence 3 from Patent EP2371958. JA538119 - Sequence 4 from Patent EP2371958. JB251938 - Sequence 5 from Patent EP2440214. JB251939 - Sequence 6 from Patent EP2440214. JE980380 - Sequence 71 from Patent EP2862929. JE980381 - Sequence 72 from Patent EP2862929. LP764837 - Sequence 5 from Patent EP3276004. LP764838 - Sequence 6 from Patent EP3276004. AF229178 - Homo sapiens leucine rich repeat and death domain containing protein (LRDD) mRNA, complete cds. AB209529 - Homo sapiens mRNA for leucine rich repeat and death domain containing protein isoform 1 variant protein. JD162179 - Sequence 143203 from Patent EP1572962. AL833849 - Homo sapiens mRNA; cDNA DKFZp434D229 (from clone DKFZp434D229). BC014904 - Homo sapiens leucine-rich repeats and death domain containing, mRNA (cDNA clone MGC:16925 IMAGE:3908102), complete cds. AK074893 - Homo sapiens cDNA FLJ90412 fis, clone NT2RP3000059, weakly similar to ANKYRIN, BRAIN VARIANT 2. AB208949 - Homo sapiens mRNA for Hypothetical protein DKFZp434D229 variant protein. AB208832 - Homo sapiens mRNA for Hypothetical protein DKFZp434D229 variant protein. JD123389 - Sequence 104413 from Patent EP1572962. JD443150 - Sequence 424174 from Patent EP1572962. JD103964 - Sequence 84988 from Patent EP1572962. JD098048 - Sequence 79072 from Patent EP1572962. JD123172 - Sequence 104196 from Patent EP1572962. AF274972 - Homo sapiens PIDD (PIDD) mRNA, complete cds, alternatively spliced. EU176211 - Synthetic construct Homo sapiens clone IMAGE:100006460; FLH185967.01X; RZPDo839G05250D leucine-rich repeats and death domain containing (LRDD) gene, encodes complete protein. JD444719 - Sequence 425743 from Patent EP1572962. JD493823 - Sequence 474847 from Patent EP1572962. JD322605 - Sequence 303629 from Patent EP1572962. JD547990 - Sequence 529014 from Patent EP1572962. JD459867 - Sequence 440891 from Patent EP1572962. JD393187 - Sequence 374211 from Patent EP1572962. JD055468 - Sequence 36492 from Patent EP1572962. JD246622 - Sequence 227646 from Patent EP1572962. JD101442 - Sequence 82466 from Patent EP1572962. JD260304 - Sequence 241328 from Patent EP1572962. JD479712 - Sequence 460736 from Patent EP1572962. JD139475 - Sequence 120499 from Patent EP1572962. JD339186 - Sequence 320210 from Patent EP1572962. JD196502 - Sequence 177526 from Patent EP1572962. JD157690 - Sequence 138714 from Patent EP1572962. JD140817 - Sequence 121841 from Patent EP1572962. JD408523 - Sequence 389547 from Patent EP1572962.
| |
|
|
Biochemical and Signaling Pathways
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: ENST00000347755.1, ENST00000347755.2, ENST00000347755.3, ENST00000347755.4, ENST00000347755.5, ENST00000347755.6, ENST00000347755.7, ENST00000347755.8, ENST00000347755.9, LRDD , NM_145886, PIDD , PIDD1 , PIDD1_HUMAN, Q59FD1, Q59H10, Q59HC7, Q7Z4P8, Q8NC89, Q8NDL2, Q96C25, Q9HB75, Q9NRE6, uc317xon.1, uc317xon.2 UCSC ID: ENST00000347755.10_11 RefSeq Accession: NM_145886.4
Protein: Q9HB75
(aka PIDD_HUMAN)
| |
|
|
Gene Model Information
|
|
Click here
for a detailed description of the fields of the table above.
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|